U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Abnormal nonverbal communicative behavior

MedGen UID:
867425
Concept ID:
C4021798
Mental or Behavioral Dysfunction
Synonyms: Impaired use of nonverbal behaviors; Impaired use of nonverbal behaviours
 
HPO: HP:0000758

Definition

Abnormalities in eye contact, communicative facial expressions, gesture use, or the use of others' bodies to communicate convey shared meanings within a culture that replace or supplement verbal communication. [from HPO]

Conditions with this feature

Autism
MedGen UID:
13966
Concept ID:
C0004352
Mental or Behavioral Dysfunction
Autism, the prototypic pervasive developmental disorder (PDD), is usually apparent by 3 years of age. It is characterized by a triad of limited or absent verbal communication, a lack of reciprocal social interaction or responsiveness, and restricted, stereotypic, and ritualized patterns of interests and behavior (Bailey et al., 1996; Risch et al., 1999). 'Autism spectrum disorder,' sometimes referred to as ASD, is a broader phenotype encompassing the less severe disorders Asperger syndrome (see ASPG1; 608638) and pervasive developmental disorder, not otherwise specified (PDD-NOS). 'Broad autism phenotype' includes individuals with some symptoms of autism, but who do not meet the full criteria for autism or other disorders. Mental retardation coexists in approximately two-thirds of individuals with ASD, except for Asperger syndrome, in which mental retardation is conspicuously absent (Jones et al., 2008). Genetic studies in autism often include family members with these less stringent diagnoses (Schellenberg et al., 2006). Levy et al. (2009) provided a general review of autism and autism spectrum disorder, including epidemiology, characteristics of the disorder, diagnosis, neurobiologic hypotheses for the etiology, genetics, and treatment options. Genetic Heterogeneity of Autism Autism is considered to be a complex multifactorial disorder involving many genes. Accordingly, several loci have been identified, some or all of which may contribute to the phenotype. Included in this entry is AUTS1, which has been mapped to chromosome 7q22. Other susceptibility loci include AUTS3 (608049), which maps to chromosome 13q14; AUTS4 (608636), which maps to chromosome 15q11; AUTS6 (609378), which maps to chromosome 17q11; AUTS7 (610676), which maps to chromosome 17q21; AUTS8 (607373), which maps to chromosome 3q25-q27; AUTS9 (611015), which maps to chromosome 7q31; AUTS10 (611016), which maps to chromosome 7q36; AUTS11 (610836), which maps to chromosome 1q41; AUTS12 (610838), which maps to chromosome 21p13-q11; AUTS13 (610908), which maps to chromosome 12q14; AUTS14A (611913), which has been found in patients with a deletion of a region of 16p11.2; AUTS14B (614671), which has been found in patients with a duplication of a region of 16p11.2; AUTS15 (612100), associated with mutation in the CNTNAP2 gene (604569) on chromosome 7q35-q36; AUTS16 (613410), associated with mutation in the SLC9A9 gene (608396) on chromosome 3q24; AUTS17 (613436), associated with mutation in the SHANK2 gene (603290) on chromosome 11q13; AUTS18 (615032), associated with mutation in the CHD8 gene (610528) on chromosome 14q11; AUTS19 (615091), associated with mutation in the EIF4E gene (133440) on chromosome 4q23; and AUTS20 (618830), associated with mutation in the NLGN1 gene (600568) on chromosome 3q26. (NOTE: the symbol 'AUTS2' has been used to refer to a gene on chromosome 7q11 (KIAA0442; 607270) and therefore is not used as a part of this autism locus series.) There are several X-linked forms of autism susceptibility: AUTSX1 (300425), associated with mutations in the NLGN3 gene (300336); AUTSX2 (300495), associated with mutations in NLGN4 (300427); AUTSX3 (300496), associated with mutations in MECP2 (300005); AUTSX4 (300830), associated with variation in the region on chromosome Xp22.11 containing the PTCHD1 gene (300828); AUTSX5 (300847), associated with mutations in the RPL10 gene (312173); and AUTSX6 (300872), associated with mutation in the TMLHE gene (300777). A locus on chromosome 2q (606053) associated with a phenotype including intellectual disability and speech deficits was formerly designated AUTS5. Folstein and Rosen-Sheidley (2001) reviewed the genetics of autism.
Asperger syndrome, susceptibility to, 1
MedGen UID:
325218
Concept ID:
C1837646
Disease or Syndrome
Asperger syndrome is considered to be a form of childhood autism (see, e.g., 209850). The DSM-IV (American Psychiatric Association, 1994) specifies several diagnostic criteria for Asperger syndrome, which has many of the same features as autism. In general, patients with Asperger syndrome and autism exhibit qualitative impairment in social interaction, as manifest by impairment in the use of nonverbal behaviors such as eye-to-eye gaze, facial expression, body postures, and gestures, failure to develop appropriate peer relationships, and lack of social sharing or reciprocity. Patients also exhibit restricted, repetitive and stereotyped patterns of behavior, interests, and activities, including abnormal preoccupation with certain activities and inflexible adherence to routines or rituals. Asperger syndrome is primarily distinguished from autism by the higher cognitive abilities and a more normal and timely development of language and communicative phrases. Gillberg et al. (2001) described the development of the Asperger syndrome (and high-functioning autism) Diagnostic Interview (ASDI), which they claimed has a strong validity in the diagnosis of the disorder. Genetic Heterogeneity of Susceptibility to Asperger Syndrome ASPG1 maps to chromosome 3q. Other autosomal loci include ASPG2 (608631) on chromosome 17p, ASPG3 (608781) on 1q21-q22, and ASPG4 (609954) on 3p24-p21.
Asperger syndrome, susceptibility to, 2
MedGen UID:
332517
Concept ID:
C1837697
Disease or Syndrome
Asperger syndrome is considered to be a form of childhood autism (see, e.g., 209850). The DSM-IV (American Psychiatric Association, 1994) specifies several diagnostic criteria for Asperger syndrome, which has many of the same features as autism. In general, patients with Asperger syndrome and autism exhibit qualitative impairment in social interaction, as manifest by impairment in the use of nonverbal behaviors such as eye-to-eye gaze, facial expression, body postures, and gestures, failure to develop appropriate peer relationships, and lack of social sharing or reciprocity. Patients also exhibit restricted, repetitive and stereotyped patterns of behavior, interests, and activities, including abnormal preoccupation with certain activities and inflexible adherence to routines or rituals. Asperger syndrome is primarily distinguished from autism by the higher cognitive abilities and a more normal and timely development of language and communicative phrases. Gillberg et al. (2001) described the development of the Asperger syndrome (and high-functioning autism) Diagnostic Interview (ASDI), which they claimed has a strong validity in the diagnosis of the disorder. For a discussion of genetic heterogeneity of Asperger syndrome, see ASPG1 (608638).
Autism, susceptibility to, 3
MedGen UID:
334211
Concept ID:
C1842632
Finding
Autism, the prototypic pervasive developmental disorder (PDD), is usually apparent by 3 years of age. It is characterized by a triad of limited or absent verbal communication, a lack of reciprocal social interaction or responsiveness, and restricted, stereotypic, and ritualized patterns of interests and behavior (Bailey et al., 1996; Risch et al., 1999). 'Autism spectrum disorder,' sometimes referred to as ASD, is a broader phenotype encompassing the less severe disorders Asperger syndrome (see ASPG1; 608638) and pervasive developmental disorder, not otherwise specified (PDD-NOS). 'Broad autism phenotype' includes individuals with some symptoms of autism, but who do not meet the full criteria for autism or other disorders. Impaired intellectual development coexists in approximately two-thirds of individuals with ASD, except for Asperger syndrome, in which impaired intellectual development is conspicuously absent (Jones et al., 2008). Genetic studies in autism often include family members with these less stringent diagnoses (Schellenberg et al., 2006). For a discussion of genetic heterogeneity of autism, see 209850. See also chromosome 13q14 deletion syndrome (613884), in which retinoblastoma and impaired intellectual development are features.
Autism, susceptibility to, X-linked 3
MedGen UID:
335161
Concept ID:
C1845336
Finding
The spectrum of MECP2-related phenotypes in females ranges from classic Rett syndrome to variant Rett syndrome with a broader clinical phenotype (either milder or more severe than classic Rett syndrome) to mild learning disabilities; the spectrum in males ranges from severe neonatal encephalopathy to pyramidal signs, parkinsonism, and macroorchidism (PPM-X) syndrome to severe syndromic/nonsyndromic intellectual disability. Females: Classic Rett syndrome, a progressive neurodevelopmental disorder primarily affecting girls, is characterized by apparently normal psychomotor development during the first six to 18 months of life, followed by a short period of developmental stagnation, then rapid regression in language and motor skills, followed by long-term stability. During the phase of rapid regression, repetitive, stereotypic hand movements replace purposeful hand use. Additional findings include fits of screaming and inconsolable crying, autistic features, panic-like attacks, bruxism, episodic apnea and/or hyperpnea, gait ataxia and apraxia, tremors, seizures, and acquired microcephaly. Males: Severe neonatal-onset encephalopathy, the most common phenotype in affected males, is characterized by a relentless clinical course that follows a metabolic-degenerative type of pattern, abnormal tone, involuntary movements, severe seizures, and breathing abnormalities. Death often occurs before age two years.
Autism, susceptibility to, X-linked 2
MedGen UID:
336964
Concept ID:
C1845539
Finding
Autism, the prototypic pervasive developmental disorder (PDD), is usually apparent by 3 years of age. It is characterized by a triad of limited or absent verbal communication, a lack of reciprocal social interaction or responsiveness, and restricted, stereotypic, and ritualized patterns of interests and behavior (Bailey et al., 1996; Risch et al., 1999). 'Autism spectrum disorder,' sometimes referred to as ASD, is a broader phenotype encompassing the less severe disorders Asperger syndrome (see ASPG1; 608638) and pervasive developmental disorder, not otherwise specified (PDD-NOS). 'Broad autism phenotype' includes individuals with some symptoms of autism, but who do not meet the full criteria for autism or other disorders. Impaired intellectual development coexists in approximately two-thirds of individuals with ASD, except for Asperger syndrome, in which intellectual disability is conspicuously absent (Jones et al., 2008). Genetic studies in autism often include family members with these less stringent diagnoses (Schellenberg et al., 2006). For a discussion of genetic heterogeneity of autism, see 209850.
Autism, susceptibility to, X-linked 1
MedGen UID:
335205
Concept ID:
C1845540
Finding
Autism, the prototypic pervasive developmental disorder (PDD), is usually apparent by 3 years of age. It is characterized by a triad of limited or absent verbal communication, a lack of reciprocal social interaction or responsiveness, and restricted, stereotypic, and ritualized patterns of interests and behavior (Bailey et al., 1996; Risch et al., 1999). 'Autism spectrum disorder,' sometimes referred to as ASD, is a broader phenotype encompassing the less severe disorders Asperger syndrome (see ASPG1; 608638) and pervasive developmental disorder, not otherwise specified (PDD-NOS). 'Broad autism phenotype' includes individuals with some symptoms of autism, but who do not meet the full criteria for autism or other disorders. Mental retardation coexists in approximately two-thirds of individuals with ASD, except for Asperger syndrome, in which mental retardation is conspicuously absent (Jones et al., 2008). Genetic studies in autism often include family members with these less stringent diagnoses (Schellenberg et al., 2006). For a discussion of genetic heterogeneity of autism, see 209850.
Autism, susceptibility to, 8
MedGen UID:
409897
Concept ID:
C1969710
Finding
Autism, the prototypic pervasive developmental disorder (PDD), is usually apparent by 3 years of age. It is characterized by a triad of limited or absent verbal communication, a lack of reciprocal social interaction or responsiveness, and restricted, stereotypical, and ritualized patterns of interests and behavior (Bailey et al., 1996; Risch et al., 1999). 'Autism spectrum disorder,' sometimes referred to as ASD, is a broader phenotype encompassing the less severe disorders Asperger syndrome (see ASPG1; 608638) and pervasive developmental disorder, not otherwise specified (PDD-NOS). 'Broad autism phenotype' includes individuals with some symptoms of autism, but who do not meet the full criteria for autism or other disorders. Mental retardation coexists in approximately two-thirds of individuals with ASD, except for Asperger syndrome, in which mental retardation is conspicuously absent (Jones et al., 2008). Genetic studies in autism often include family members with these less stringent diagnoses (Schellenberg et al., 2006). For a discussion of genetic heterogeneity of autism, see 209850.
15q11q13 microduplication syndrome
MedGen UID:
390767
Concept ID:
C2675336
Disease or Syndrome
Maternal 15q duplication syndrome (maternal dup15q) is characterized by hypotonia and motor delays, intellectual disability, autism spectrum disorder (ASD), and epilepsy including infantile spasms. Rarely, maternal dup15q may also be associated with psychosis or sudden unexplained death. Those with a maternal isodicentric 15q11.2-q13.1 supernumerary chromosome are typically more severely affected than those with an interstitial duplication.

Professional guidelines

PubMed

Burdeus-Olavarrieta M, Nevado J, van Weering-Scholten S, Parker S; European Phelan-McDermid syndrome consortium, Swillen A
Eur J Med Genet 2023 May;66(5):104745. Epub 2023 Mar 5 doi: 10.1016/j.ejmg.2023.104745. PMID: 36871884
Martin L, Gitsels-van der Wal JT, Pereboom MT, Spelten ER, Hutton EK, van Dulmen S
Patient Educ Couns 2016 Jan;99(1):85-91. Epub 2015 Jul 22 doi: 10.1016/j.pec.2015.07.020. PMID: 26298217
Friedlander AH, Yagiela JA, Paterno VI, Mahler ME
J Am Dent Assoc 2006 Nov;137(11):1517-27. doi: 10.14219/jada.archive.2006.0086. PMID: 17082277

Recent clinical studies

Etiology

O'Toole C, Lee AS, Gibbon FE, van Bysterveldt AK, Hart NJ
Cochrane Database Syst Rev 2018 Oct 15;10(10):CD012089. doi: 10.1002/14651858.CD012089.pub2. PMID: 30321454Free PMC Article
Mandy W, Wang A, Lee I, Skuse D
J Child Psychol Psychiatry 2017 Oct;58(10):1166-1175. Epub 2017 Jul 25 doi: 10.1111/jcpp.12785. PMID: 28741680
Khalifeh S, Yassin W, Kourtian S, Boustany RM
J Med Liban 2016 Aug;64(2):110-115. PMID: 30452150
Grieco J, Pulsifer M, Seligsohn K, Skotko B, Schwartz A
Am J Med Genet C Semin Med Genet 2015 Jun;169(2):135-49. Epub 2015 May 18 doi: 10.1002/ajmg.c.31439. PMID: 25989505
Essa MM, Braidy N, Vijayan KR, Subash S, Guillemin GJ
Neurotox Res 2013 May;23(4):393-400. Epub 2012 Oct 13 doi: 10.1007/s12640-012-9354-3. PMID: 23065398

Diagnosis

Gavazzi F, Vaia Y, Woidill S, Formanowski B, Peixoto de Barcelos I, Sevagamoorthy A, Modesti NB, Charlton L, Cusack SV, Vincent A, D'Aiello R, Jawad A, Galli J, Varesio C, Fazzi E, Orcesi S, Glanzman AM, Lorch S, DeMauro SB, Guez-Barber D, Waldman AT, Vanderver A, Adang LA
Neurology 2024 Jul 9;103(1):e209541. Epub 2024 Jun 10 doi: 10.1212/WNL.0000000000209541. PMID: 38857477Free PMC Article
AlRuwaili A, Fatima R, Hussain A, Uzair M, Abualait T, Imdad K, Bashir S
CNS Neurol Disord Drug Targets 2024;23(8):1030-1039. doi: 10.2174/0118715273249412231010171926. PMID: 37846576
Kosztyła-Hojna B, Moskal-Jasińska D, Kraszewska A, Łobaczuk-Sitnik A, Zdrojkowski M, Duchnowska E, Biszewska J
Otolaryngol Pol 2019 Apr 5;73(4):14-20. doi: 10.5604/01.3001.0013.0999. PMID: 31474620
Mandy W, Wang A, Lee I, Skuse D
J Child Psychol Psychiatry 2017 Oct;58(10):1166-1175. Epub 2017 Jul 25 doi: 10.1111/jcpp.12785. PMID: 28741680
Khalifeh S, Yassin W, Kourtian S, Boustany RM
J Med Liban 2016 Aug;64(2):110-115. PMID: 30452150

Therapy

O'Toole C, Lee AS, Gibbon FE, van Bysterveldt AK, Hart NJ
Cochrane Database Syst Rev 2018 Oct 15;10(10):CD012089. doi: 10.1002/14651858.CD012089.pub2. PMID: 30321454Free PMC Article
Herzig L, de Lacy N, Capone G, Radesky J
J Dev Behav Pediatr 2018 Sep;39(7):591-593. doi: 10.1097/DBP.0000000000000613. PMID: 30134288
Khalifeh S, Yassin W, Kourtian S, Boustany RM
J Med Liban 2016 Aug;64(2):110-115. PMID: 30452150
Hermann B, Meador KJ, Gaillard WD, Cramer JA
Epilepsy Behav 2010 Jan;17(1):1-5. doi: 10.1016/j.yebeh.2009.10.019. PMID: 19931492
Gray KM, Tonge BJ
J Paediatr Child Health 2001 Jun;37(3):221-6. doi: 10.1046/j.1440-1754.2001.00653.x. PMID: 11468034

Prognosis

Burdeus-Olavarrieta M, Nevado J, van Weering-Scholten S, Parker S; European Phelan-McDermid syndrome consortium, Swillen A
Eur J Med Genet 2023 May;66(5):104745. Epub 2023 Mar 5 doi: 10.1016/j.ejmg.2023.104745. PMID: 36871884
Hokstad S, Næss KB, Yaruss JS, Hoff K, Melle AH, Lervåg AO
J Speech Lang Hear Res 2022 Nov 17;65(11):4133-4150. Epub 2022 Oct 27 doi: 10.1044/2022_JSLHR-21-00605. PMID: 36302044
Neal CN, Brady NC, Fleming KK
Am J Intellect Dev Disabil 2022 Jan 1;127(1):11-28. doi: 10.1352/1944-7558-127.1.11. PMID: 34979037
Ward R, Sanoudaki E
J Commun Disord 2021 Sep-Oct;93:106126. Epub 2021 Jun 1 doi: 10.1016/j.jcomdis.2021.106126. PMID: 34126402
Khalifeh S, Yassin W, Kourtian S, Boustany RM
J Med Liban 2016 Aug;64(2):110-115. PMID: 30452150

Clinical prediction guides

Gavazzi F, Vaia Y, Woidill S, Formanowski B, Peixoto de Barcelos I, Sevagamoorthy A, Modesti NB, Charlton L, Cusack SV, Vincent A, D'Aiello R, Jawad A, Galli J, Varesio C, Fazzi E, Orcesi S, Glanzman AM, Lorch S, DeMauro SB, Guez-Barber D, Waldman AT, Vanderver A, Adang LA
Neurology 2024 Jul 9;103(1):e209541. Epub 2024 Jun 10 doi: 10.1212/WNL.0000000000209541. PMID: 38857477Free PMC Article
Hokstad S, Næss KB, Yaruss JS, Hoff K, Melle AH, Lervåg AO
J Speech Lang Hear Res 2022 Nov 17;65(11):4133-4150. Epub 2022 Oct 27 doi: 10.1044/2022_JSLHR-21-00605. PMID: 36302044
Neal CN, Brady NC, Fleming KK
Am J Intellect Dev Disabil 2022 Jan 1;127(1):11-28. doi: 10.1352/1944-7558-127.1.11. PMID: 34979037
O'Toole C, Lee AS, Gibbon FE, van Bysterveldt AK, Hart NJ
Cochrane Database Syst Rev 2018 Oct 15;10(10):CD012089. doi: 10.1002/14651858.CD012089.pub2. PMID: 30321454Free PMC Article
Wills S, Cabanlit M, Bennett J, Ashwood P, Amaral D, Van de Water J
Ann N Y Acad Sci 2007 Jun;1107:79-91. doi: 10.1196/annals.1381.009. PMID: 17804535

Recent systematic reviews

Lulu C, Xie H, Wang P, Zhang T
PLoS One 2023;18(12):e0294326. Epub 2023 Dec 8 doi: 10.1371/journal.pone.0294326. PMID: 38064440Free PMC Article
Djuwantono T, Aviani JK, Permadi W, Halim D, Achmad TH, Dhamayanti M
J Neurodev Disord 2023 Aug 22;15(1):26. doi: 10.1186/s11689-023-09490-0. PMID: 37608302Free PMC Article
O'Toole C, Lee AS, Gibbon FE, van Bysterveldt AK, Hart NJ
Cochrane Database Syst Rev 2018 Oct 15;10(10):CD012089. doi: 10.1002/14651858.CD012089.pub2. PMID: 30321454Free PMC Article

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...